检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Combination of IFNL4 polymorphisms and ALT reduction at 4 week of treatment with PEG IFN and Ribavirin is a new selection tool to optimize antiviral treatment allocation in HCV patients with low stage fibrosis

Figorilli Francesco,Onali Simona, Cantone Stefania,Argentini Claudio,Casu Stefania,Balestrieri Cinzia,Conti Maria,Serra Giancarlo,Casale Michele, Pasetto Maria Cristina,Matta Laura,Barca Lucia,Scioscia Rosetta,I Canini, Quaranta Maria Giovanna,Genovese Domenico,Vella Stefano,Chessa Luchino

HEPATOLOGY（2015）

引用 4|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要